PETER FUTRELL: Open Payments
NPI 1912990391 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,785 in 224 payments from 39 companies in 2025. Trend: 2023 $3,963 · 2024 $4,581 · 2025 $4,785
Food & beverage: $4,785
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 45 | $578 |
| Neurocrine BioSciences, Inc. | 14 | $339 |
| ABBVIE INC. | 28 | $330 |
| UCB, Inc. | 8 | $291 |
| Biogen, Inc. | 10 | $256 |
| Novartis Pharmaceuticals Corporation | 9 | $253 |
| Eisai Inc. | 13 | $249 |
| ACADIA Pharmaceuticals Inc | 9 | $239 |
| Lilly USA, LLC | 10 | $238 |
| Lundbeck LLC | 7 | $184 |
Products named: NURTEC ODT, INGREZZA, Leqembi, KESIMPTA, UBRELVY, NUPLAZID, Rystiggo, TYSABRI.
Industry payments across GA — which companies pay providers there.
